🇺🇸 FDA
Company

Arcutis

Arcutis Biotherapeutics

ARQT pharma USA

Quick answer

Arcutis is a pharma company (ARQT) headquartered in WESTLAKE VILLAGE, CA, USA with 24 tracked pipeline programs.

Pipeline (24)

project

ARQ-151 0.3% cream

Chronic Plaque Psoriasis

Phase 3 · small_molecule · completed

1 trials project

ARQ-151 Cream 0.15% or ARQ-151 Cream 0.05%

Atopic Dermatitis Eczema

Phase 3 · small_molecule · completed

1 trials project

Roflumilast 0.3% cream

Chronic Plaque Psoriasis

Phase 3 · small_molecule · completed

1 trials project

Roflumilast Cream

Atopic Dermatitis Eczema

Phase 3 · small_molecule · completed

1 trials project

Roflumilast Cream 0.05%

Atopic Dermatitis Eczema

Phase 3 · small_molecule · completed

1 trials project

Roflumilast Cream 0.15%

Atopic Dermatitis Eczema

Phase 3 · small_molecule · completed

1 trials project

Roflumilast Foam

Seborrheic Dermatitis

Phase 3 · small_molecule · completed

1 trials project

Roflumilast Foam 0.3%

Scalp Psoriasis

Phase 3 · small_molecule · completed

1 trials project

Topical roflumilast

Chronic Plaque Psoriasis

Phase 3 · small_molecule · completed

1 trials project

ARQ-151 cream 0.05%

Atopic Dermatitis (Eczema)

Phase 2 · small_molecule · completed

1 trials project

ARQ-151 cream 0.3%

Psoriasis

Phase 2 · small_molecule · completed

2 trials project

ARQ-151 cream 0.5%

Psoriasis

Phase 2 · small_molecule · completed

1 trials project

ARQ-154

Seborrheic Dermatitis

Phase 2 · small_molecule · completed

1 trials project

ARQ-252 cream 0.3%

Vitiligo

Phase 2 · small_molecule · terminated

1 trials project

ARQ-252 cream 0.3%

Chronic Hand Eczema

Phase 2 · small_molecule · completed

1 trials project

Roflumilast

Plaque Psoriasis

Phase 2 · small_molecule · completed

1 trials project

Roflumilast Cream 0.05%

Atopic Dermatitis

Phase 2 · small_molecule · completed

1 trials project

Roflumilast Cream 0.3%

Plaque Psoriasis

Phase 2 · small_molecule · completed

1 trials project

Roflumilast Foam 0.3%

Seborrheic Dermatitis

Phase 2 · small_molecule · completed

1 trials project

Roflumilast foam 0.3%

Plaque Psoriasis

Phase 2 · small_molecule · completed

1 trials project

Roflumilast topical 0.3% foam

Non-segmental Vitiligo

Phase 2 · small_molecule · active

1 trials project

Topical roflumilast 0.3% foam

Hidradenitis Suppurativa

Phase 2 · small_molecule · active

1 trials project

ARQ-151 cream 0.15%

Atopic Dermatitis (Eczema)

Phase 1 · small_molecule · completed

1 trials project

ARQ-151- cream 0.3%

Plaque Psoriasis

Phase 1 · small_molecule · completed

1 trials

Drugs (1)

drug

roflumilast

ROFLUMILAST

Patents (8)

patent

US 12390453

Method for reducing side effects from administration of phosphodiesterase-4 inhi

Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12336983

Inhibition of crystal growth of roflumilast

Expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12329751

Topical roflumilast formulation having antifungal properties

Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12310956

Topical roflumilast formulation having improved delivery and plasma half-life

Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12257242

Inhibition of crystal growth of roflumilast

Expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12220409

Roflumilast formulations with an improved pharmacokinetic profile

Expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12161643

Stable formulations of SHR0302

Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12144802

Pharmaceutical compositions of roflumilast and solvents capable of dissolving hi

Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)